Natural killer cell receptor—Repertoire and functions after induction therapy by polyclonal rabbit anti-thymocyte globulin in unsensitized kidney transplant recipients

Autor: Cedric Bandelier, Laure Valloton, Pierre-Yves Martin, Yannick Avila, Leo Buhler, Sylvie Ferrari-Lacraz, Casimir de Rham, Giuseppe Pantaleo, Manuel Pascual, Karine Hadaya, Jean Villard
Rok vydání: 2010
Předmět:
Cytotoxicity
Immunologic

Graft Rejection
Male
Interleukin-12/pharmacology
Lysosomal-Associated Membrane Protein 1/metabolism
medicine.medical_treatment
Kidney Transplantation/*immunology
Lymphocytes/cytology/drug effects
NK Cell Lectin-Like Receptor Subfamily C/metabolism
Receptors
KIR

Antilymphocyte Serum/*pharmacology/therapeutic use
Immunology and Allergy
Interferon gamma
Lymphocytes
ddc:616
Aged
80 and over

ddc:617
Immunosuppression
Middle Aged
Interleukin-12
Killer Cells
Natural

medicine.anatomical_structure
Interleukin 12
Receptors
Natural Killer Cell

Female
Rabbits
Receptors
KIR/metabolism

NK Cell Lectin-Like Receptor Subfamily C
medicine.drug
Adult
Immunology
Biology
Receptors
Natural Cytotoxicity Triggering

Cytotoxicity
Immunologic/immunology

Natural killer cell
Interferon-gamma
Young Adult
Lysosomal-Associated Membrane Protein 1
Receptors
Natural Cytotoxicity Triggering/metabolism

medicine
Animals
Humans
Lymphocyte Count
Antilymphocyte Serum
Aged
Interferon-gamma/metabolism
Graft Rejection/prevention & control
Killer Cells
Natural/cytology/drug effects/*immunology/*metabolism

Receptors
Natural Killer Cell/*metabolism

Cytotoxicity Tests
Immunologic

NKG2D
Kidney Transplantation
Anti-thymocyte globulin
Transplantation
K562 Cells
Zdroj: Clinical Immunology, Vol. 137, No 2 (2010) pp. 250-260
ISSN: 1521-6616
Popis: Polyclonal rabbit anti-thymocyte globulin (rATG) is widely used in solid organ transplantation (SOT) as induction therapy or to treat corticosteroid-resistant rejection. In vivo, the effect of rATG on natural killer (NK) cells has not been studied. These cells are of particular relevance after SOT because classical immunosuppressive drugs do not inhibit or even can activate NK cells. A cohort of 20 recipients at low immunological risk, that had been receiving rATG as induction therapy, was analyzed for receptor repertoire, cytotoxicity and capacity of NK cells to secrete IFN-gamma before kidney transplantation and at different time points thereafter. NK cells expressed fewer killer-cell immunoglobulin-like receptors (KIR), fewer activating receptors NKG2D, but more inhibitory receptor NKG2A compatible with an immature phenotype in the first 6 months post transplantation. Both cytotoxicity of NK cells and the secretion of IFN-gamma were preserved over time after transplantation.
Databáze: OpenAIRE